Sleep Medicine
Volume 2, Issue 2 , Pages 161-163 , March 2001

Article reviewed: Serum leptin and vascular risk factors in obstructive sleep apnea

,Accepted 13 December 2000.

References 

  1. O'Donnell CP, Schaub CD, Haines AS, Berkowitz DE, et al.  Leptin prevents respiratory depression in obesity. J Respir Crit Care Med. 1999;159:1477–1484
  2. Tankersley CG, O'Donnell C, Daood MJ, Watchko JF, et al.  Leptin attenuates respiratory complications associated with the obese phenotype. J Appl Physiol. 1998;85:2261–2269
  3. Chin K, Shimizu K, Nakamura T, Narai N, et al.  Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999;100:706–712
  4. Snitker S, Prately RE, Nicolson M, Tatarranni PA, Ravussin E. Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obesity Res. 1997;5:338–340
  5. Heymesfield SB, Greenberg AS, Fujioka K, Dixon RM, et al.  Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose escalated trial. J Am Med Assoc. 1999;282:1568–1575
  6. Engleman H, Asgari JN, McLeod AL, Ramsay CF, et al.  Self-reported use of CPAP and benefits of CPAP therapy. A patient survey. Chest. 1996;109:1470–1476

 M.Sm. Ip, K.S.L. Lam, C. Ho, K.W.T. Tsang, W. Lam, (Chest 2000;118:580-586).

PII: S1389-9457(01)00074-0

Sleep Medicine
Volume 2, Issue 2 , Pages 161-163 , March 2001